Ranitidine (ATLANTIC BIOLOGICALS CORP.)


Welcome to the PulseAid listing for the Ranitidine drug offered from ATLANTIC BIOLOGICALS CORP.. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: ATLANTIC BIOLOGICALS CORP.
NON-PROPRIETARY NAME: Ranitidine
SUBSTANCE NAME: RANITIDINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
ROUTE: ORAL
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2009-09-19
END MARKETING DATE: 0000-00-00


Ranitidine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRanitidine from ATLANTIC BIOLOGICALS CORP.
LABELER NAME: ATLANTIC BIOLOGICALS CORP.
DEA SCHEDULE:
ACTIVE STRENGTH: 15(mg/mL)
START MARKETING DATE: 2009-09-19
END MARKETING DATE: 0000-00-00
PRODUCT ID: 17856-0727_4ca3b7ed-3b83-4209-916d-99a17dfaab3e
PRODUCT NDC: 17856-0727
APPLICATION NUMBER: ANDA077405

Other RANITIDINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
ATLANTIC BIOLOGICALS CORP.Ranitidine
McKesson Packaging Services Business Unit of McKesson CorporationRanitidine
Pharmaceutical Associates, Inc.Ranitidine
Sandoz Inc.Ranitidine
State of Florida DOH Central PharmacyRanitidine